Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001774690-26-000002

Options or other derivatives

  • Chief Financial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Leggett Thomas Chief Financial Officer 2026-02-17 Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000 D
Leggett Thomas Chief Financial Officer 2026-02-17 Grant or award · Restricted Stock Units +40,000 40,000 D
Loading xslF345X05/form4-02192026_090230.xml…